New insider activity at Procter & Gamble ( (PG) ) has taken place on May 1, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Jennifer L. Davis, the CEO of Health Care at Procter & Gamble, has recently sold 1,000 shares of the company’s stock, amounting to a total transaction value of $161,380.
Spark’s Take on PG Stock
According to Spark, TipRanks’ AI Analyst, PG is a Outperform.
Procter & Gamble’s overall stock score reflects strong financial performance and a solid market position. The company’s effective cost management, innovation, and dividend yield are strengths. However, a premium valuation and technical indicators suggesting a neutral outlook are concerns. The earnings call and recent corporate events highlight strategic initiatives and growth potential, supporting a stable investment outlook.
To see Spark’s full report on PG stock, click here.
More about Procter & Gamble
YTD Price Performance: -2.26%
Average Trading Volume: 8,552,511
Technical Sentiment Signal: Sell
Current Market Cap: $379.5B